Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 813,654 | 940,208 | 880,396 | 582,930 |
| Gross Profit | -813,654 | -940,208 | -880,396 | -582,930 |
| Selling General And Administration | 4.8M | 5.6M | 13.0M | 12.5M |
| General And Administrative Expense | 4.8M | 5.6M | 13.0M | 12.5M |
| Research And Development | 711,506 | 1.3M | 1.2M | -- |
| Other Operating Expenses | 54.0M | 95.7M | 73.7M | 43.6M |
| Operating Expense | 60.4M | 103.1M | 87.8M | 56.1M |
| Operating Income | -61.2M | -104.1M | -88.7M | -56.7M |
| EBIT | -50.2M | -79.9M | -90.0M | -50.6M |
| Interest Expense | 25,105 | 27,119 | 15,988 | 7,493 |
| Interest Expense Non Operating | 25,105 | 27,119 | 15,988 | 7,493 |
| Interest Income | 2.9M | 2.8M | 1.2M | 122,714 |
| Interest Income Non Operating | 2.9M | 2.8M | 1.2M | 122,714 |
| Net Interest Income | 2.8M | 2.8M | 1.2M | 115,221 |
| Other Income Expense | 8.1M | 21.4M | -2.5M | 5.9M |
| Other Non Operating Income Expenses | 12.4M | 22.9M | 17.2M | 6.6M |
| Special Income Charges | -1.8M | 3.2M | 14,188 | 470,811 |
| Write Off | 0.00 | 1.0M | 0.00 | -- |
| Gain On Sale Of Security | -1.2M | -3.9M | -19.7M | -1.2M |
| Earnings From Equity Interest | -1.3M | -795,995 | 0.00 | -- |
| Pretax Income | -50.3M | -79.9M | -90.0M | -50.6M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Income From Continuing Operation Net Minority Interest | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Income Including Noncontrolling Interests | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Income Common Stockholders | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Income | -50.3M | -79.9M | -90.0M | -50.6M |
| EBITDA | -49.4M | -78.9M | -89.1M | -50.0M |
| Normalized EBITDA | -46.5M | -78.2M | -69.5M | -49.3M |
| Reconciled Depreciation | 813,654 | 940,208 | 880,396 | 582,930 |
| Basic EPS | -0.26 | -0.45 | -0.54 | -0.33 |
| Diluted EPS | -0.26 | -0.45 | -0.54 | -0.33 |
| Basic Average Shares | 194.0M | 178.4M | 166.9M | 154.9M |
| Diluted Average Shares | 194.0M | 178.4M | 166.9M | 154.9M |
| Total Unusual Items | -3.0M | -739,735 | -19.6M | -710,814 |
| Total Unusual Items Excluding Goodwill | -3.0M | -739,735 | -19.6M | -710,814 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -47.3M | -79.2M | -70.3M | -49.9M |
| Diluted NI Availto Com Stockholders | -50.3M | -79.9M | -90.0M | -50.6M |
| Gain On Sale Of Ppe | 0.00 | 4.2M | 12,161 | 499,415 |
| Impairment Of Capital Assets | 0.00 | 8,000 | 0.00 | 28,604 |
| Net Income Continuous Operations | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Non Operating Interest Income Expense | 2.8M | 2.8M | 1.2M | 115,221 |
| Other Gand A | 1.3M | 1.7M | 1.6M | 1.8M |
| Other Special Charges | 1.8M | -- | -2,027 | -- |
| Other Taxes | 928,769 | 584,120 | 0.00 | -- |
| Reconciled Cost Of Revenue | 813,654 | 940,208 | 880,396 | 582,930 |
| Salaries And Wages | 3.5M | 3.9M | 11.4M | 10.7M |
| Total Expenses | 61.2M | 104.1M | 88.7M | 56.7M |
| Total Operating Income As Reported | -60.3M | -103.5M | -88.7M | -56.7M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 22.3M | 53.9M | 82.2M | 100.5M |
| Cash Cash Equivalents And Short Term Investments | 23.1M | 57.3M | 89.6M | 129.1M |
| Cash Financial | 22.3M | 53.9M | 82.2M | 100.5M |
| Other Short Term Investments | 779,019 | 3.4M | 7.5M | 28.6M |
| Accounts Receivable | -- | -- | -- | 0.00 |
| Receivables | 5.0M | 3.4M | 3.1M | 1.8M |
| Prepaid Assets | 1.5M | 1.5M | 1.4M | 2.2M |
| Other Current Assets | -- | -- | 76,303 | 107,376 |
| Current Assets | 29.8M | 62.4M | 94.3M | 136.5M |
| Gross PPE | 45.4M | 19.0M | 17.7M | 12.3M |
| Accumulated Depreciation | -2.8M | -2.1M | -1.4M | -729,687 |
| Net PPE | 42.6M | 16.9M | 16.4M | 11.5M |
| Investments And Advances | 1.5M | 2.9M | 0.00 | -- |
| Long Term Equity Investment | 1.5M | 2.9M | 0.00 | -- |
| Other Non Current Assets | 179,703 | -- | -- | -- |
| Total Non Current Assets | 44.3M | 22.2M | 16.4M | 11.5M |
| Total Assets | 74.0M | 84.6M | 110.7M | 148.1M |
| Current Debt And Capital Lease Obligation | 53,783 | 88,958 | 81,388 | 54,250 |
| Payables And Accrued Expenses | 4.9M | 5.2M | 5.6M | 2.6M |
| Other Current Liabilities | -- | 12.4M | 20.1M | 10.1M |
| Current Liabilities | 7.4M | 19.0M | 27.1M | 12.8M |
| Long Term Debt And Capital Lease Obligation | 69,320 | 68,839 | 68,839 | 46,600 |
| Long Term Capital Lease Obligation | 69,320 | 68,839 | 68,839 | 46,600 |
| Other Non Current Liabilities | -- | -- | -- | 12.6M |
| Total Non Current Liabilities Net Minority Interest | 69,320 | 68,839 | 68,839 | 12.6M |
| Total Liabilities Net Minority Interest | 7.4M | 19.1M | 27.2M | 25.4M |
| Common Stock | 341.3M | 290.2M | 229.6M | 181.8M |
| Capital Stock | 341.3M | 290.2M | 229.6M | 181.8M |
| Retained Earnings | -309.8M | -259.5M | -179.6M | -89.6M |
| Gains Losses Not Affecting Retained Earnings | 35.0M | 34.8M | 33.4M | 30.5M |
| Common Stock Equity | 66.6M | 65.5M | 83.5M | 122.7M |
| Stockholders Equity | 66.6M | 65.5M | 83.5M | 122.7M |
| Total Equity Gross Minority Interest | 66.6M | 65.5M | 83.5M | 122.7M |
| Total Capitalization | 66.6M | 65.5M | 83.5M | 122.7M |
| Net Tangible Assets | 66.6M | 65.5M | 83.5M | 122.7M |
| Tangible Book Value | 66.6M | 65.5M | 83.5M | 122.7M |
| Working Capital | 22.4M | 43.4M | 67.2M | 123.8M |
| Invested Capital | 66.6M | 65.5M | 83.5M | 122.7M |
| Total Debt | 123,103 | 157,797 | 150,227 | 100,850 |
| Share Issued | 200.5M | 186.9M | 175.4M | 164.2M |
| Ordinary Shares Number | 200.5M | 186.9M | 175.4M | 164.2M |
| Accrued Interest Receivable | 0.00 | 75,322 | 0.00 | -- |
| Buildings And Improvements | -- | -- | -- | 97,258 |
| Capital Lease Obligations | 123,103 | 157,797 | 150,227 | 100,850 |
| Current Capital Lease Obligation | 53,783 | 88,958 | 81,388 | 54,250 |
| Current Provisions | 2.4M | 1.3M | 1.4M | -- |
| Hedging Assets Current | 147,000 | 188,500 | 26,868 | 3.4M |
| Investmentsin Associatesat Cost | 1.5M | 2.9M | 0.00 | -- |
| Machinery Furniture Equipment | 4.3M | 3.4M | 2.5M | 1.4M |
| Non Current Note Receivables | 0.00 | 2.5M | 0.00 | -- |
| Notes Receivable | 2.8M | 0.00 | -- | -- |
| Other Equity Interest | -- | 34.8M | 33.4M | -- |
| Other Properties | 41.1M | 15.6M | 15.3M | 10.9M |
| Taxes Receivable | 2.2M | 3.3M | 3.1M | 1.8M |
| Treasury Shares Number | -- | 0.00 | -- | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -55.7M | -99.3M | -74.4M | -48.5M |
| Cash Flow From Continuing Operating Activities | -55.7M | -99.3M | -74.4M | -48.5M |
| Depreciation And Amortization | 813,654 | 940,208 | 880,396 | 582,930 |
| Depreciation Amortization Depletion | 813,654 | 940,208 | 880,396 | 582,930 |
| Stock Based Compensation | 889,045 | 1.4M | 8.5M | 7.6M |
| Change In Working Capital | 1.3M | -604,651 | 3.8M | -170,181 |
| Changes In Account Receivables | -- | -- | 0.00 | 2,837 |
| Change In Receivables | 1.1M | -230,680 | -1.3M | -779,976 |
| Change In Payables And Accrued Expense | 164,636 | -170,689 | 4.3M | 1.6M |
| Change In Other Current Assets | 0.00 | -106,179 | 38,008 | -107,211 |
| Other Non Cash Items | -11.0M | -22.9M | -17.2M | -6.6M |
| Capital Expenditure | -4.5M | -1.7M | -5.6M | -5.4M |
| Purchase Of PPE | -4.5M | -1.7M | -5.6M | -5.4M |
| Net PPE Purchase And Sale | -4.5M | -1.7M | -5.5M | -5.4M |
| Purchase Of Investment | 0.00 | -2.6M | 0.00 | -12.9M |
| Sale Of Investment | 1.1M | 0.00 | 4.8M | 1.3M |
| Net Investment Purchase And Sale | 1.1M | -2.6M | 4.8M | -11.5M |
| Investing Cash Flow | -3.0M | -4.4M | -737,874 | -17.1M |
| Cash Flow From Continuing Investing Activities | -3.0M | -4.4M | -737,874 | -17.1M |
| Repayment Of Debt | -134,001 | -143,957 | -121,775 | -100,500 |
| Net Issuance Payments Of Debt | -134,001 | -143,957 | -121,775 | -100,500 |
| Issuance Of Capital Stock | 27.5M | 79.0M | 52.5M | 120.5M |
| Net Common Stock Issuance | 27.5M | 79.0M | 52.5M | 120.5M |
| Financing Cash Flow | 27.1M | 75.4M | 56.8M | 118.3M |
| Cash Flow From Continuing Financing Activities | 27.1M | 75.4M | 56.8M | 118.3M |
| Effect Of Exchange Rate Changes | 2,861 | 0.00 | -- | -- |
| Changes In Cash | -31.6M | -28.3M | -18.3M | 52.8M |
| Beginning Cash Position | 53.9M | 82.2M | 100.5M | 47.7M |
| End Cash Position | 22.3M | 53.9M | 82.2M | 100.5M |
| Free Cash Flow | -60.2M | -101.0M | -80.0M | -53.9M |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 25,105 | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | 0.00 | 1.0M | 0.00 | 28,604 |
| Capital Expenditure Reported | -5,550 | -16,565 | -16,294 | -- |
| Cash Dividends Paid | 0.00 | 0.00 | -- | 0.00 |
| Change In Prepaid Assets | 38,816 | -97,103 | 757,003 | -920,854 |
| Common Stock Issuance | 27.5M | 79.0M | 52.5M | 120.5M |
| Depreciation | 813,654 | 940,208 | 880,396 | 582,930 |
| Earnings Losses From Equity Investments | 1.3M | 795,995 | 0.00 | -- |
| Gain Loss On Investment Securities | 380,877 | -- | 4.7M | -192,114 |
| Gain Loss On Sale Of Business | 28,772 | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | 0.00 | -4.1M | -12,161 | -499,415 |
| Interest Paid Cff | -25,105 | -27,119 | -- | -6,516 |
| Interest Received Cfi | 378,040 | 0.00 | -- | -- |
| Long Term Debt Payments | -134,001 | -143,957 | -121,775 | -100,500 |
| Net Foreign Currency Exchange Gain Loss | -224,187 | 43,299 | 0.00 | -- |
| Net Income From Continuing Operations | -50.3M | -79.9M | -90.0M | -50.6M |
| Net Long Term Debt Issuance | -134,001 | -143,957 | -121,775 | -100,500 |
| Net Other Financing Charges | -1.1M | -3.5M | -3.3M | -4.5M |
| Net Other Investing Changes | -- | -94,752 | -16,294 | -111,130 |
| Operating Gains Losses | 1.5M | -3.3M | 4.7M | -691,529 |
| Proceeds From Stock Option Exercised | 862,500 | 131,630 | 7.7M | 2.4M |
| Sale Of PPE | 0.00 | 9,084 | 12,161 | 0.00 |
| Unrealized Gain Loss On Investment Securities | 1.1M | 4.0M | 14.9M | 1.4M |